decitabine,
Showing 376 - 400 of 493
MDS, Acute Myeloid Leukemia Trial in France (Guadecitabine)
Unknown status
- Myelodysplastic Syndromes
- Acute Myeloid Leukemia
-
Angers, France
- +11 more
Nov 13, 2018
FLT3-ITD Mutation, Acute Myeloid Leukemia, Brutons Tyrosine Kinase Trial in Guangzhou (Ibrutinib)
Enrolling by invitation
- FLT3-ITD Mutation
- +2 more
-
Guangzhou, Guangdong, ChinaDepartment of Hematology,Nanfang Hospital, Southern Medical Univ
Aug 20, 2018
AML, Relapse Trial in Beijing (Chidamide plus DCAG regimen)
Unknown status
- AML
- Relapse
- Chidamide plus DCAG regimen
-
Beijing, ChinaChina PLA General Hospital
Feb 12, 2018
Acute Myeloid Leukemia With Multilineage Dysplasia, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute
Completed
- Acute Myeloid Leukemia With Multilineage Dysplasia
- +8 more
- tosedostat
- +2 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Feb 13, 2017
Acute Myeloid Leukemia, Adult Trial (Decitabine, Cytarabine)
Unknown status
- Acute Myeloid Leukemia, Adult
- (no location specified)
Dec 3, 2016
Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML) Trial in France, Germany (drug, procedure, other, genetic)
Terminated
- Myelodysplastic Syndrome (MDS)
- Acute Myeloid Leukemia (AML)
- JNJ-56022473
- +8 more
-
Nantes, France
- +9 more
Oct 23, 2018
Leukemia, Myeloid, Acute, MDS Trial in St. Louis (LBH589, Decitabine)
Completed
- Leukemia, Myeloid, Acute
- Myelodysplastic Syndromes
-
St. Louis, MissouriWashington University
Aug 18, 2016
Minimal Residual Disease,Acute Leukemia, Hypomethylating Agents, Donor Lymphocyte Infusion, Allogeneic Hematopoietic Cell
Unknown status
- Minimal Residual Disease,Acute Leukemia, Hypomethylating Agents, Donor Lymphocyte Infusion, Allogeneic Hematopoietic Cell Transplantation
- HMA+DLI
- DLI
-
Guangzhou, Guangdong, ChinaDepartment of Hematology,Nanfang Hospital, Southern Medical Univ
Sep 5, 2018
MDS Trial in Shanghai (CHG regimen, 5-aza-deoxycytidine)
Unknown status
- Myelodysplastic Syndromes
- CHG regimen
- 5-aza-deoxycytidine
-
Shanghai, Shanghai, ChinaShanghai 6th People's Hospital
Sep 8, 2016
Sarcoma, Melanoma, Epithelial Malignancies Trial run by the NCI (Epigenetically Modified Autologous Tumor, Cyclophosphamide,
Terminated
- Sarcoma
- +3 more
- Epigenetically Modified Autologous Tumor
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jul 3, 2018
Chemotherapy vs No Chemotherapy Pre-transplant to MDS Undergoing
Unknown status
- Myelodysplastic Syndrome
- Chemotherapy
- Demethylation drug
- Chemotherapy regimen
-
Guangzhou, Guangdong, ChinaDepartment of Hematology,Nanfang Hospital, Southern Medical Univ
Dec 6, 2017
Recurrent Adult Acute Myeloid Leukemia Trial in Beijing (Deciatbine(DAC))
Unknown status
- Recurrent Adult Acute Myeloid Leukemia
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Aug 29, 2016
Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (Clofarabine, Cytarabine, Decitabine)
Completed
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- Clofarabine
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jun 15, 2016
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid
Completed
- Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
- +7 more
- decitabine
- +8 more
-
Columbus, OhioOhio State University Medical Center
May 18, 2016
Myelodysplastic Syndrome Trial in New York (Tosedostat)
Completed
- Myelodysplastic Syndrome
-
New York, New YorkWeill Cornell Medical College
Jun 7, 2018
MDS Trial in Beijing (Microtransplantation)
Completed
- Myelodysplastic Syndromes
- Microtransplantation
-
Beijing, Beijing, ChinaAffiliated Hospital of Academy of Military Medical Sciences
Jul 12, 2016
Acute Myeloid Leukemia, Myeloproliferative Tumors, MDS Trial in Sao Paulo (Induction Chemotherapy, Consolidation Chemotherapy,
Completed
- Acute Myeloid Leukemia
- +3 more
- Induction Chemotherapy
- +5 more
-
Sao Paulo, SP, BrazilHospital Israelita Albert Einstein
Nov 7, 2016
Myelodysplastic Syndrome Trial in China (Decitabine at 15 mg/m2, Decitabine at 20 mg/m2)
Completed
- Myelodysplastic Syndrome
- Decitabine at 15 mg/m2
- Decitabine at 20 mg/m2
-
Beijing, China
- +7 more
Apr 1, 2016
MDS Trial in Italy (5-Azacytidine, Valproic Acid, ATRA)
Immune Thrombocytopenia Trial in Assiut (Hydroxychloroquine, vincristine, azathioprine)
Completed
- Immune Thrombocytopenia
- Hydroxychloroquine
- +2 more
-
Assiut, EgyptAssiut university hospital
Jun 27, 2018